News Briefs In torturous IPO market, life sciences deals outnumber tech 4 to 1 Mark Boslet - 24 August 2016 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
